BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17521249)

  • 21. Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.
    Nappi RE; Kaunitz AM; Bitzer J
    Eur J Contracept Reprod Health Care; 2016; 21(2):106-15. PubMed ID: 26572318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compliance and use behaviour, an issue in injectable as well as oral contraceptive use? A study of injectable and oral contraceptive use in Johannesburg.
    Beksinska ME; Rees VH; Nkonyane T; McIntyre JA
    Br J Fam Plann; 1998 Apr; 24(1):21-3. PubMed ID: 9719703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Menstrual nirvana: amenorrhea through the use of continuous oral contraceptives.
    Edelman A
    Curr Womens Health Rep; 2002 Dec; 2(6):434-8. PubMed ID: 12429077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combined hormonal contraception in cycles artificially extended].
    Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
    Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rationale for new oral contraceptive dosing.
    Williams JK
    Int J Fertil Womens Med; 2004; 49(1):30-5. PubMed ID: 15038507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of breast self-examination prompts on oral contraceptive packaging.
    Ferris DG; Golden NH; Petry LJ; Litaker MS; Nackenson M; Woodward LD
    J Fam Pract; 1996 Jan; 42(1):43-8. PubMed ID: 8537804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding profile of a flexible extended regimen of ethinylestradiol/drospirenone in US women: an open-label, three-arm, active-controlled, multicenter study.
    Jensen JT; Garie SG; Trummer D; Elliesen J
    Contraception; 2012 Aug; 86(2):110-8. PubMed ID: 22281416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives.
    Wiegratz I; Hommel HH; Zimmermann T; Kuhl H
    Contraception; 2004 Jan; 69(1):37-42. PubMed ID: 14720618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spanish women's attitudes towards menstruation and use of a continuous, daily use hormonal combined contraceptive regimen.
    Sánchez-Borrego R; García-Calvo C
    Contraception; 2008 Feb; 77(2):114-7. PubMed ID: 18226675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial selection of oral contraceptives.
    Reiter SL; Baer LJ
    J Reprod Med; 1990 May; 35(5):547-8. PubMed ID: 2352250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual suppression: benefits and risks of continuous combined oral contraceptives.
    Dougherty PL
    Nurs Womens Health; 2008 Jun; 12(3):243-8. PubMed ID: 18557855
    [No Abstract]   [Full Text] [Related]  

  • 33. The shorter, the better: A review of the evidence for a shorter contraceptive hormone-free interval.
    Graziottin A
    Eur J Contracept Reprod Health Care; 2016; 21(2):93-105. PubMed ID: 26291185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
    Seidman DS; Yeshaya A; Ber A; Amodai I; Feinstein I; Finkel I; Gordon N; Porat N; Samuel D; Shiran-Makler E; Wolman I
    Isr Med Assoc J; 2010 Jul; 12(7):400-5. PubMed ID: 20862819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new ultra-low-dose combination oral contraceptive.
    Woutersz TB
    J Reprod Med; 1983 Jan; 28(1 Suppl):81-4. PubMed ID: 6403705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an oral contraceptive containing drospirenone in an extended regimen.
    Sillem M; Schneidereit R; Heithecker R; Mueck AO
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended- and continuous-cycle oral contraceptives.
    Shrader SP; Dickerson LM
    Pharmacotherapy; 2008 Aug; 28(8):1033-40. PubMed ID: 18657019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Switching hormonal contraceptives to a chlormadinone acetate-containing oral contraceptive. The Contraceptive Switch Study.
    Schramm G; Heckes B
    Contraception; 2007 Aug; 76(2):84-90. PubMed ID: 17656175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pill-a-month as an oral contraceptive.
    Hefnawi F; Hassanein M; Younis N
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):1-17. PubMed ID: 12256024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Women's preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.
    Nappi RE; Fiala C; Chabbert-Buffet N; Häusler G; Jamin C; Lete I; Lukasiewic M; Pintiaux A; Lobo P
    Eur J Contracept Reprod Health Care; 2016 Jun; 21(3):242-50. PubMed ID: 27010535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.